-
Ivermectin: Mechanistic Assay Design in Parasitology
2026-08-14
Ivermectin is a broad-spectrum anti-parasitic compound whose value in research depends on rigorous formulation, controls, and orthogonal readouts. This article uses the GSDMC–PDAC study as a methodological model for distinguishing phenotype from mechanism without overextending cross-domain evidence.
-
RSV NS3 Rewires Host Kinase Signaling
2026-08-14
Zhuang et al. demonstrate that Rice stripe virus NS3 does not simply suppress host defense; its abundance and phosphorylation state redirect the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway at different infection stages. The work provides a mechanistic model for balancing viral pathogenicity, transmission, and host-vector survival across rice and the small brown planthopper.
-
KLF7–ITGA2 Targets Oral Cancer Stemness
2026-08-13
The 2025 Cell Death and Disease study identifies ITGA2 as a direct KLF7-regulated driver of oral squamous cell carcinoma stemness. Its data indicate that inhibiting the ITGA2–collagen interaction with TC-I 15 can weaken tumor-initiating capacity and improve cisplatin response in xenograft models.
-
Carvedilol Workflows for β-Adrenergic Research
2026-08-13
Carvedilol is a dual β- and α1-adrenergic antagonist for dissecting receptor signaling, oxidative stress, vascular remodeling, and regeneration biology. This practical guide connects dose selection and assay controls with new evidence that nonselective β-blockade can alter hematopoietic recovery after allogeneic transplantation.
-
HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody
2026-08-12
Build brighter, more reproducible rabbit-primary detection workflows across immunofluorescence, tissue imaging, flow cytometry, and plate assays. HyperFluor™ 594 combines a red-shifted 590/617 nm fluorescence profile with affinity-purified goat anti-rabbit IgG recognition for multiplex-ready experimental design.
-
Tamsulosin: From Meta-Analysis to Assay Design
2026-08-12
Tamsulosin is more than a clinical smooth-muscle relaxant: its evidence base can guide endpoint selection, exposure design, and translational assay quality. This article converts ureteral-stone meta-analysis findings into a rigorous framework for GPCR, urological, and smooth-muscle research.
-
Imatinib Hydrochloride: From ATP Blockade to Translation
2026-08-11
Imatinib hydrochloride, also known as STI571 hydrochloride, is more than a familiar ATP-site inhibitor. Its value in chronic myelogenous leukemia research and gastrointestinal stromal tumor research lies in the opportunity to connect biochemical target inhibition with cellular state, pathway adaptation, and translational decision-making. This article examines how to deploy the compound as a mechanistic probe, how recent work on kinase conformational control and phosphatase access broadens the interpretation of inhibitor data, and how researchers can build more reproducible, hypothesis-driven studies.
-
JNJ-10198409: PDGF Signaling for Translation
2026-08-11
A mechanistic and translational perspective on using JNJ-10198409 to interrogate PDGF-BB receptor signaling in angiogenesis, tumor biology, and fibrotic disorder research, while distinguishing established evidence from cross-domain hypotheses.
-
RRP Restores Lipid Metabolism in Liver Injury
2026-08-10
The reference study shows that Radix Rehmanniae Praeparata extracts reduce hepatic ischemia-reperfusion injury in mice and lipid-loaded hepatocytes by restoring cholesterol homeostasis. Its mechanistic contribution is the identification of an AMPK–mTOR pathway that restrains SCAP–SREBP2-driven cholesterol synthesis while promoting LXRα-dependent cholesterol efflux.
-
Ciprofloxacin in Resistance Transmission Workflows
2026-08-09
Ciprofloxacin gives antimicrobial resistance research a controllable fluoroquinolone perturbation for linking phenotype, DNA replication inhibition, and mobile resistance determinants. This guide translates hospital-isolate findings into practical susceptibility, conjugation, and assay-optimization workflows.
-
Okadaic acid: PP1/PP2A Workflow Guide
2026-08-08
Okadaic acid (SKU A4540) provides a controlled way to inhibit PP2A preferentially at low nanomolar potency and PP1 at higher concentrations in biochemical and cell-based studies. It is useful for phosphatase inhibition, phosphorylation signaling, and apoptosis assay workflows, but cellular dose selection, solvent controls, and model-specific validation are essential.
-
Toremifene: A Mechanistic Lens on Prostate Cancer
2026-08-07
Explore how Toremifene, a selective estrogen-receptor modulator, can support prostate cancer research at the intersection of estrogen receptor signaling, calcium entry, and metastatic phenotypes. This article translates the TSPAN18–STIM1 study into practical assay decisions without overstating an unproven drug–pathway connection.
-
Chloroquine Diphosphate: Autophagy Modulation and Cancer Res
2026-08-07
Chloroquine diphosphate is a well-characterized autophagy modulator and TLR7/TLR9 inhibitor, widely used for cancer research and therapy sensitization. Its unique mechanistic profile enables cell cycle arrest and enhances chemosensitivity in tumor cell models. This article provides a structured, evidence-backed overview of its biological rationale, mechanism, and translational applications.
-
Chloroquine Diphosphate in Autophagy and Chemotherapy Sensit
2026-08-06
Chloroquine diphosphate, a potent TLR7/9 inhibitor and autophagy modulator, enhances chemotherapy efficacy by disrupting cancer cell survival pathways. This guide details its experimental workflows, integration in cancer research, and troubleshooting for robust, reproducible results.
-
ROS-Mediated Cell Cycle Arrest by CGF Suppresses Colorectal
2026-08-06
Jiang et al. reveal that Cya-Gly-Fer (CGF), an anthocyanin derivative from purple sweet potato, suppresses colorectal cancer progression by inducing mitochondrial dysfunction and reactive oxygen species (ROS) overload. This leads to metabolic reprogramming, cell cycle arrest, and apoptosis, highlighting CGF's therapeutic promise and the value of mechanistic cell cycle assays in cancer research.